JP2002514180A5 - - Google Patents

Download PDF

Info

Publication number
JP2002514180A5
JP2002514180A5 JP1998512818A JP51281898A JP2002514180A5 JP 2002514180 A5 JP2002514180 A5 JP 2002514180A5 JP 1998512818 A JP1998512818 A JP 1998512818A JP 51281898 A JP51281898 A JP 51281898A JP 2002514180 A5 JP2002514180 A5 JP 2002514180A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP1998512818A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002514180A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1997/015444 external-priority patent/WO1998009957A1/en
Publication of JP2002514180A publication Critical patent/JP2002514180A/ja
Publication of JP2002514180A5 publication Critical patent/JP2002514180A5/ja
Abandoned legal-status Critical Current

Links

JP51281898A 1996-09-04 1997-09-02 マトリックスメタロプロテイナーゼを阻害するための化合物およびその方法 Abandoned JP2002514180A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2506396P 1996-09-04 1996-09-04
US60/025,063 1996-09-04
US5571497P 1997-08-07 1997-08-07
US60/055,714 1997-08-07
PCT/US1997/015444 WO1998009957A1 (en) 1996-09-04 1997-09-02 Compounds for and a method of inhibiting matrix metalloproteinases

Publications (2)

Publication Number Publication Date
JP2002514180A JP2002514180A (ja) 2002-05-14
JP2002514180A5 true JP2002514180A5 (https=) 2005-04-07

Family

ID=26699217

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51281898A Abandoned JP2002514180A (ja) 1996-09-04 1997-09-02 マトリックスメタロプロテイナーゼを阻害するための化合物およびその方法

Country Status (10)

Country Link
US (1) US6294674B1 (https=)
EP (1) EP0929542A1 (https=)
JP (1) JP2002514180A (https=)
KR (1) KR20000068415A (https=)
AU (1) AU736347B2 (https=)
BR (1) BR9712794A (https=)
CA (1) CA2256631A1 (https=)
HR (1) HRP970474B1 (https=)
NZ (1) NZ333064A (https=)
WO (1) WO1998009957A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100413859C (zh) * 1996-01-23 2008-08-27 盐野义制药株式会社 磺化的氨基酸衍生物及含有它的金属蛋白酶抑制剂
US6919375B1 (en) 1996-01-23 2005-07-19 Shionogi & Co., Ltd. Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
CA2263886A1 (en) * 1996-12-09 1998-06-18 Warner-Lambert Company Method for treating and preventing heart failure and ventricular dilatation
ATE261954T1 (de) * 1998-07-30 2004-04-15 Warner Lambert Co Tricyclische sulfonamide und ihre derivate als inhibitoren von matrix-metalloproteinasen
WO2000006560A1 (en) * 1998-07-30 2000-02-10 Warner-Lambert Company Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases
WO2000015213A1 (en) * 1998-09-11 2000-03-23 Shionogi & Co., Ltd. Remedal or preventive agent for congestive heart failure
PL358272A1 (en) * 2000-03-27 2004-08-09 The Scripps Research Institute Methods for inhibiting angiogenesis and tumor growth
GB2365425A (en) * 2000-08-01 2002-02-20 Parke Davis & Co Ltd Alkyl amino acid derivatives useful as pharmaceutical agents
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US20030129672A1 (en) * 2001-08-29 2003-07-10 Dyer Richard Dennis Method for identifying metalloenzyme inhibitors
PE20030701A1 (es) 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
EP2181704B1 (en) 2002-12-30 2015-05-06 Angiotech International Ag Drug delivery from rapid gelling polymer composition
CN1318411C (zh) * 2005-03-21 2007-05-30 中国海洋大学 氢化轮枝霉酮类化合物及其制备方法和用途
AU2006332694A1 (en) * 2005-12-30 2007-07-12 Alantos Pharmaceuticals, Holding, Inc. Substituted bis-amide metalloprotease inhibitors
WO2008057254A2 (en) * 2006-10-27 2008-05-15 Wyeth Tricyclic compounds as matrix metalloproteinase inhibitors
GB0621973D0 (en) * 2006-11-03 2006-12-13 Philogen Spa Binding molecules and uses thereof
CL2008001257A1 (es) * 2007-05-04 2008-07-04 Wyeth Corp Compuestos triciclicos, inhibidores de metaloproteinasas matriciales; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis reumatoide, osteoartritis, aterosclerosis, cancer de pulmon, entre otras.
BRPI0813176A2 (pt) * 2007-06-15 2014-12-30 Mission Pharma Co Moléculas e composições par ainibir fator edema e adenilil ciclase
JP2012051804A (ja) * 2008-12-26 2012-03-15 Kyoto Univ Eg5阻害剤
TWI854164B (zh) * 2016-02-01 2024-09-01 美商百歐克斯製藥公司 苯并吡唑化合物及其類似物
CN114981251B (zh) * 2020-01-21 2023-11-21 深圳信立泰药业股份有限公司 一种二苯并呋喃类衍生物组织蛋白酶k抑制剂及其制备方法和医药用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845097A (en) 1969-09-06 1974-10-29 Ajinomoto Kk N-substituted amino acids and novel ester
DE2065966C3 (de) 1969-09-06 1978-11-16 Ajinomoto Co., Inc., Tokio N-Fluorenyl-sulfonyl-aminocarbonsäuren sowie diese enthaltende Mittel
US4097472A (en) 1974-11-08 1978-06-27 Mitsubishi Chemical Industries Limited N2 -arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof
DE2236876C3 (de) * 1971-08-19 1981-02-12 Ajinomoto Co., Inc., Tokio N-Substituierte Aminocarbonsäuren und diese Verbindungen enthaltende Arzneimittel
EP0183271B1 (en) * 1984-11-30 1990-05-16 Shosuke Okamoto Lysin derivative and proteinase inhibitor
PH31294A (en) * 1992-02-13 1998-07-06 Thomae Gmbh Dr K Benzimidazolyl derivatives, pharmaceutical compositions containing these compounds and process for preparing them.
US5455258A (en) 1993-01-06 1995-10-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5665764A (en) 1995-06-02 1997-09-09 Warner-Lambert Company Tricyclic inhibitors of matrix metalloproteinases
US5627206A (en) 1995-06-02 1997-05-06 Warner-Lambert Company Tricyclic inhibitor of matrix metalloproteinases
JPH11506097A (ja) 1995-06-02 1999-06-02 ワーナー−ランバート・コンパニー マトリックスメタロプロテイナーゼの三環式阻害剤
IL123901A (en) 1995-11-17 2003-06-24 Warner Lambert Co Sulfonamide inhibitors of matrix metalloproteinases and pharmaceutical compositions comprising them
CN100413859C (zh) * 1996-01-23 2008-08-27 盐野义制药株式会社 磺化的氨基酸衍生物及含有它的金属蛋白酶抑制剂
BR9711988A (pt) 1996-09-04 1999-08-24 Warner Lambert Co Inibidores de metaloproteinase de matriz e seus empregos terap-uticos

Similar Documents

Publication Publication Date Title
JP2001502742A5 (https=)
JP2000502280A5 (https=)
JP2000501771A5 (https=)
JP2000501599A5 (https=)
JP2000500076A5 (https=)
JP2000500055A5 (https=)
JP2000500026A5 (https=)
JP2001511883A5 (https=)
JP2000502472A5 (https=)
JP2000501825A5 (https=)
JP2001500643A5 (https=)
JP2000502425A5 (https=)
JP2000502485A5 (https=)
JP2000512134A5 (https=)
JP2000507001A5 (https=)
JP2000502568A5 (https=)
JP2000501774A5 (https=)
JP2000502570A5 (https=)
JP2000501876A5 (https=)
JP2000514124A5 (https=)
JP2000501744A5 (https=)
JP2000502316A5 (https=)
JP2000502714A5 (https=)
JP2000500184A5 (https=)
JP2000513348A5 (https=)